Each unit of the nasal spray contains 665mcg of olopatadine ... It is indicated for the treatment of symptoms associated with allergic rhinitis in adults and those aged 12 and over.
Antihistamines for allergic rhinitis have experienced major commercial ... the FDA would be reluctant to approve a steroid-based spray. Additionally, the incorrect use of the intranasal delivery ...
For patients with allergic rhinitis, twice-daily azelastine plus ... all treatments were administered as one spray twice daily to preserve blinding. The studies were sponsored by a company that ...
50mcg/spray. Mometasone is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic rhinitis is not known. Treatment of ...
Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...
Safety and effectiveness of azelastine HCl nasal spray, 0.1% in pediatric patients below the age of 5 years with seasonal allergic rhinitis and in pediatric patients below the age of 12 years with ...
Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark has been the ...